Cipro ciprofloxacin regulatory update

FDA granted Orphan Drug designation for Bayer's ciprofloxacin dry powder inhaler (DPI) for the management of pulmonary infection due to Psuedomonas aeruginosa in cystic fibrosis (CF) patients. The inh...